Medicamen Biotech share price
MEDICAMEQ on NSE · data as of 16 Oct 2026
Medicamen Biotech closed at ₹284.45 on 16 Oct 2026 (−3.45% on the day). It is 36.5% below its 52-week high of ₹447.65 (25 Nov 2025) and 33.9% above its 52-week low of ₹212.40 (29 Jun 2026). The stock has outperformed the Nifty 50 over the past year (-8.2% vs -8.5%). It is trading above both its 50-day and 200-day averages (an uptrend), with RSI 40 (neutral zone).
Technical snapshot
- 20-day averagebelow, 8.4%
- 50-day averageabove, 1.1%
- 200-day averageabove, 0.4%
- RSI (14)40 neutral zone
- MACDbelow signal line
- Streakdown 7 days in a row
- 20-day rangeclosed below the 20-day low
- Typical daily move1.8% last 20 days
- Beta vs Nifty 500.79 moves less than the market
- Traded value today₹0.7 cr 1x the 20-day average volume
Key levels
- Nearest resistance₹299.70 5.4% above
- Nearest support₹264.15 7.1% below
- Position in 52-week range31% 0 = low, 100 = high
Weekly pivot levels (₹)
Chart pattern
No clear double or triple top or bottom, or head-and-shoulders shape, in the last six months.
Support and resistance are recent swing lows and highs; pivots come from last week's high, low and close. Patterns and candles describe past prices only. They are not predictions or buy/sell signals. Terms explained: double top, head and shoulders, neckline, MACD, pivot, delivery %, beta, traded value.
Where the price sits
Last 12 months
Weekly closing prices, adjusted for splits and bonus issues.
Returns vs Nifty 50
| Period | MEDICAMEQ | Nifty 50 | Gap |
|---|---|---|---|
| 1 week | −5.5% | +2.8% | −8.3 pts |
| 1 month | −17.7% | −0.3% | −17.4 pts |
| 3 months | +19.2% | −4.9% | +24.1 pts |
| 6 months | +14.3% | −4.3% | +18.6 pts |
| 1 year | −8.2% | −8.5% | +0.3 pts |
Gap = the stock's return minus the Nifty 50's, in percentage points. New to these terms? See 52-week high, moving average and RSI.
Quick answers
What is the 52-week high of Medicamen Biotech?
The 52-week high of Medicamen Biotech (MEDICAMEQ) is ₹447.65, reached on 25 Nov 2025. The 52-week low is ₹212.40, on 29 Jun 2026 (NSE, as of 16 Oct 2026).
How has Medicamen Biotech performed in the last year?
Over the last year the share price has moved -8.2%, compared with -8.5% for the Nifty 50 (as of 16 Oct 2026). Past returns do not predict future returns.
Does Medicamen Biotech show a chart pattern?
As of 16 Oct 2026, there is no clear double or triple top or bottom, or head-and-shoulders shape, in the last six months.
Is Medicamen Biotech in an uptrend?
As of 16 Oct 2026, Medicamen Biotech is trading above both its 50-day and 200-day averages (an uptrend), with RSI 40 (neutral zone). Trend describes the past, not what happens next.
Price facts only, refreshed every trading day. Not a recommendation to buy or sell. Education only. Not investment advice. All stocks · Today's stock lists